Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray

Phase 2Recruiting
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Social Anxiety Disorder

Conditions

Social Anxiety Disorder

Trial Timeline

Jan 9, 2025 → Dec 1, 2026

About Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray

Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray is a phase 2 stage product being developed by Vistagen Therapeutics for Social Anxiety Disorder. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06809179. Target conditions include Social Anxiety Disorder.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT06809179Phase 2Recruiting

Competing Products

20 competing products in Social Anxiety Disorder

See all competitors
ProductCompanyStageHype Score
LY686017 + paroxetine + placeboEli LillyPhase 2
52
atomoxetine + placeboEli LillyPhase 2/3
65
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
Cariprazine + PlaceboAbbVieApproved
85
QuetiapineAstraZenecaApproved
85
quetiapineAstraZenecaPhase 3
77
quetiapineAstraZenecaPhase 2/3
65
Seroquel + Sugar PillAstraZenecaPhase 3
77
quetiapineAstraZenecaApproved
85
Pristiq + PlaceboPfizerApproved
84
Venlafaxine ERPfizerPhase 3
76
Ziprasidone + SertralinePfizerPhase 2
51
Sertraline + PlaceboPfizerApproved
84
NefazodoneBristol Myers SquibbApproved
84
EscitalopramLundbeckApproved
82
Cipralex + PlaceboLundbeckPhase 2
49
BHV-0223 + PlaceboBiohavenPhase 2/3
60
VQW-765 + PlaceboVanda PharmaceuticalsPhase 3
69
PH94BVistagen TherapeuticsPhase 3
69
PH94B Nasal Spray + Placebo Nasal SprayVistagen TherapeuticsPhase 3
69